BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 112978
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112978
Table 2 Comparison of imaging and surgical data between groups, n (%)/mean ± SD

Favorable remodeling group (n = 95)
Adverse remodeling group (n = 45)
t/χ²
P value
True lumen diameter at primary entry tear14.45 ± 4.6911.13 ± 3.684.1370.001
False lumen diameter at primary entry tear (mm)17.05 ± 2.0520.42 ± 3.58-7.0610.001
True lumen diameter at T12 level (mm)12.66 ± 3.6210.24 ± 3.283.8040.001
False lumen diameter at T12 level (mm)15.20 ± 1.8519.58 ± 2.77-11.0600.001
Extent of false lumen involvement
Thoracic aorta7 (7.37) 07.4610.024
Suprarenal abdominal aorta41 (43.16) 13 (28.89)
Thoracoabdominal aorta47 (49.47) 32 (71.11)
Branch vessels from false lumen 1.95 ± 0.662.49 ± 0.84-4.1430.001
Entry tears in descending aorta3.04 ± 0.823.13 ± 0.82-0.6140.540
Entry tears in abdominal aorta1.95 ± 0.661.93 ± 0.650.1180.906
Patency of false lumen34 (35.79)29 (64.44)10.1310.002
Timing of surgery
Acute phase4 (4.21) 9 (20) 17.6720.001
Subacute phase88 (92.63) 29 (64.44)
Chronic phase3 (3.16) 7 (15.56)
Operative duration (minute)70.56 ± 15.1269.73 ± 17.880.0630.95
Intraoperative blood loss (mL)29.47 ± 12.9332.12 ± 15.24-0.2240.823
Left subclavian artery revascularization
Performed33 (34.74) 19 (42.22) 0.7330.392
Not performed62 (65.26) 26 (57.78)


Write to the Help Desk